June 10, 2011 – The U.S. Food and Drug Administration (FDA) announced safety label changes for the cholesterol-lowering ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
April 22, 2011 – A new study found that coronary artery bypass surgery added to medical therapy for selected ...
April 22, 2011
April 21, 2011 – A new angiotensin II receptor blocker (ARB) has been approved by the U.S. Food and Drug ...
April 21, 2011
April 21, 2011 – Baxter International has entered into a definitive agreement to acquire privately-held Prism ...
April 21, 2011April 7, 2011 – Primary results from the RADAR Phase 2b clinical trial were announced at the American College of ...
April 07, 2011
April 7, 2011 – New study results have evaluated the potential inhibitory effects of certain proton pump ...
April 07, 2011April 7, 2011 – Data from two phase 3 trials studying a drug for high-cholesterol patients who are on lipid ...
April 07, 2011
April 1, 2011 – Oral antiplatelet therapy Effient (prasugrel) has been added to the updated clinical practice ...
April 01, 2011March 25, 2011 – The American College of Cardiology (ACC) and the American Heart Association (AHA) have released a ...
March 25, 2011March 11, 2011 – Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another ...
March 11, 2011March 8, 2011 – Nile Therapeutics is pursuing a new indication for cenderitide, formerly CD-NP. The company is ...
March 08, 2011
March 8, 2011 – The U.S. Food and Drug Administration (FDA) announced monthly liver enzyme tests are no longer ...
March 07, 2011March 7, 2011 – Massachusetts General Hospital (MGH) has granted an exclusive license to Santaris Pharma A/S for ...
March 07, 2011March 7, 2011 – Nile Therapeutics will partner with Medtronic to develop natriuretic peptide, cenderitide ...
March 07, 2011
March 1, 2011 – The U.S. Food and Drug Administration (FDA) approved azilsartan medoxomil to treat high blood ...
March 01, 2011